Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon
Gespeichert in:
| Veröffentlicht in: | Revista clínica espanõla 2005-12, Vol.205 (12), p.621 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 12 |
| container_start_page | 621 |
| container_title | Revista clínica espanõla |
| container_volume | 205 |
| creator | Salgado Ordóñez, F Manteca González, R Palacios Rodríguez, S Godoy Guerrero, M |
| description | |
| doi_str_mv | 10.1016/S0014-2565(05)72656-4 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_16527184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16527184</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-a08caaf075451831a8779e6280ab3cd22a19081522a0a51d82305dc5c31122e93</originalsourceid><addsrcrecordid>eNo9j09LxDAUxHNQ3HX1Iyg56qGalzRtepRFXWFBwT_X5TV93Ua6aWlSlv32FtQ9zTAz_GAYuwJxBwKy-3chIE2kzvSN0Le5zHSWpCdsfoxn7DyEbyGkVqDO2AwyLXMw6ZyFN4yOfOR7Fxu-Wn5x2wydd5Y31E9VdIHvm443GHgYSztG9NSNgfuuGlsKHOtIA6-dd6FxfsvjQBh3R2JP20OLkSru_DSsaYJfsNMa20CXf7pgn0-PH8tVsn59flk-rJMeVBETFMYi1iLXqQajAE2eF5RJI7BUtpISoRAG9GQEaqiMVEJXVlsFICUVasGuf7n9WO6o2vSD2-Fw2Py_Vz_6Zlz4</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Salgado Ordóñez, F ; Manteca González, R ; Palacios Rodríguez, S ; Godoy Guerrero, M</creator><creatorcontrib>Salgado Ordóñez, F ; Manteca González, R ; Palacios Rodríguez, S ; Godoy Guerrero, M</creatorcontrib><identifier>ISSN: 0014-2565</identifier><identifier>DOI: 10.1016/S0014-2565(05)72656-4</identifier><identifier>PMID: 16527184</identifier><language>spa</language><publisher>Spain</publisher><subject>Antiviral Agents - adverse effects ; Antiviral Agents - therapeutic use ; Diabetes Mellitus, Type 2 - complications ; Drug Therapy, Combination ; Hepatitis C, Chronic - complications ; Hepatitis C, Chronic - drug therapy ; Humans ; Hypertension - complications ; Interferon-alpha - adverse effects ; Interferon-alpha - therapeutic use ; Middle Aged ; Polyethylene Glycols ; Recombinant Proteins ; Ribavirin - therapeutic use ; Sarcoidosis - chemically induced ; Sarcoidosis - diagnosis</subject><ispartof>Revista clínica espanõla, 2005-12, Vol.205 (12), p.621</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16527184$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salgado Ordóñez, F</creatorcontrib><creatorcontrib>Manteca González, R</creatorcontrib><creatorcontrib>Palacios Rodríguez, S</creatorcontrib><creatorcontrib>Godoy Guerrero, M</creatorcontrib><title>Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon</title><title>Revista clínica espanõla</title><addtitle>Rev Clin Esp</addtitle><subject>Antiviral Agents - adverse effects</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Drug Therapy, Combination</subject><subject>Hepatitis C, Chronic - complications</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Humans</subject><subject>Hypertension - complications</subject><subject>Interferon-alpha - adverse effects</subject><subject>Interferon-alpha - therapeutic use</subject><subject>Middle Aged</subject><subject>Polyethylene Glycols</subject><subject>Recombinant Proteins</subject><subject>Ribavirin - therapeutic use</subject><subject>Sarcoidosis - chemically induced</subject><subject>Sarcoidosis - diagnosis</subject><issn>0014-2565</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9j09LxDAUxHNQ3HX1Iyg56qGalzRtepRFXWFBwT_X5TV93Ua6aWlSlv32FtQ9zTAz_GAYuwJxBwKy-3chIE2kzvSN0Le5zHSWpCdsfoxn7DyEbyGkVqDO2AwyLXMw6ZyFN4yOfOR7Fxu-Wn5x2wydd5Y31E9VdIHvm443GHgYSztG9NSNgfuuGlsKHOtIA6-dd6FxfsvjQBh3R2JP20OLkSru_DSsaYJfsNMa20CXf7pgn0-PH8tVsn59flk-rJMeVBETFMYi1iLXqQajAE2eF5RJI7BUtpISoRAG9GQEaqiMVEJXVlsFICUVasGuf7n9WO6o2vSD2-Fw2Py_Vz_6Zlz4</recordid><startdate>200512</startdate><enddate>200512</enddate><creator>Salgado Ordóñez, F</creator><creator>Manteca González, R</creator><creator>Palacios Rodríguez, S</creator><creator>Godoy Guerrero, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200512</creationdate><title>Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon</title><author>Salgado Ordóñez, F ; Manteca González, R ; Palacios Rodríguez, S ; Godoy Guerrero, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-a08caaf075451831a8779e6280ab3cd22a19081522a0a51d82305dc5c31122e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2005</creationdate><topic>Antiviral Agents - adverse effects</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Drug Therapy, Combination</topic><topic>Hepatitis C, Chronic - complications</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Humans</topic><topic>Hypertension - complications</topic><topic>Interferon-alpha - adverse effects</topic><topic>Interferon-alpha - therapeutic use</topic><topic>Middle Aged</topic><topic>Polyethylene Glycols</topic><topic>Recombinant Proteins</topic><topic>Ribavirin - therapeutic use</topic><topic>Sarcoidosis - chemically induced</topic><topic>Sarcoidosis - diagnosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salgado Ordóñez, F</creatorcontrib><creatorcontrib>Manteca González, R</creatorcontrib><creatorcontrib>Palacios Rodríguez, S</creatorcontrib><creatorcontrib>Godoy Guerrero, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Revista clínica espanõla</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salgado Ordóñez, F</au><au>Manteca González, R</au><au>Palacios Rodríguez, S</au><au>Godoy Guerrero, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon</atitle><jtitle>Revista clínica espanõla</jtitle><addtitle>Rev Clin Esp</addtitle><date>2005-12</date><risdate>2005</risdate><volume>205</volume><issue>12</issue><spage>621</spage><pages>621-</pages><issn>0014-2565</issn><cop>Spain</cop><pmid>16527184</pmid><doi>10.1016/S0014-2565(05)72656-4</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0014-2565 |
| ispartof | Revista clínica espanõla, 2005-12, Vol.205 (12), p.621 |
| issn | 0014-2565 |
| language | spa |
| recordid | cdi_pubmed_primary_16527184 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
| subjects | Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Diabetes Mellitus, Type 2 - complications Drug Therapy, Combination Hepatitis C, Chronic - complications Hepatitis C, Chronic - drug therapy Humans Hypertension - complications Interferon-alpha - adverse effects Interferon-alpha - therapeutic use Middle Aged Polyethylene Glycols Recombinant Proteins Ribavirin - therapeutic use Sarcoidosis - chemically induced Sarcoidosis - diagnosis |
| title | Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T14%3A26%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patient%20with%20HCV%20chronic%20hepatitis%20who%20has%20subcutaneous%20nodules%20after%20finishing%20treatment%20with%20pegylated%20interferon&rft.jtitle=Revista%20cl%C3%ADnica%20espan%C3%B5la&rft.au=Salgado%20Ord%C3%B3%C3%B1ez,%20F&rft.date=2005-12&rft.volume=205&rft.issue=12&rft.spage=621&rft.pages=621-&rft.issn=0014-2565&rft_id=info:doi/10.1016/S0014-2565(05)72656-4&rft_dat=%3Cpubmed%3E16527184%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16527184&rfr_iscdi=true |